fbpx
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • Gadgets & Electronics
    • Health & Bio
    • FinTech
    • IoT
    • Transportation & Logistics
    • Marketplaces & E-commerce
    • Ecosystem
    • Robotics
    • Investments
    • EdTech
    • Featured
  • Deals
    • Private Equity
    • Venture Capital
    • IPO & Markets
  • Interviews
    • Startup Investing
    • Fundraising
    • Product Launching
  • MORE
    • Events
    • Startups Advice
  • Submit an Article
  • REGISTER
  • login
No Result
View All Result
No Result
View All Result
Home Featured

China’s Qiming Ventures raises $3.2bn for latest funds

Team AsiaTechDaily by Team AsiaTechDaily
12 July 2022
in Featured, Venture Capital
0
Qiming Ventures Partners

Photo by Jéan Béller on Unsplash

32
SHARES
Share on FacebookShare on Twitter
Bookmark (0)

Please login to bookmark

No account yet? Register

Chinese venture capital firm Qiming Ventures Partners announced the closing of its latest funds totalling $3.2 billion.

The funds include USD Fund VIII at $2.5 billion and the first closing of RMB Fund VII at RMB4.7 billion ($700 million).

As in prior funds, Fund VIII was oversubscribed and reached its hard cap for limited partner commitments. This increases the firm’s capital raised to $9.4 billion across 18 funds.

Committed capital includes the Qiming Venture Partners Fund VIII main fund that focuses on early and growth stage Technology and Consumer (T&C) and Healthcare investments and the Qiming Venture Partners Fund VIII-HC parallel healthcare fund that invests alongside the main fund.

Fund VIII is led by Managing Partners Duane Kuang, Nisa Leung, William Hu, and Gary Rieschel, with full support of investment and administration teams based in Shanghai, Beijing, Shenzhen, and Hong Kong.

Since its inception in 2006, Qiming has demonstrated its ability to deliver consistently strong venture capital returns in China.

Qiming has backed over 480 fast-growing companies, over 70 of which have achieved unicorn status. A vast majority of these companies were early stage at the time of initial investment. In addition, over 180 of our portfolio companies have achieved exits through IPO, M&A or other means, including Xiaomi, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, APT Medical, Meituan, Bilibili, and Roborock.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.

Since its debut, Qiming has backed over 480 fast-growing and innovative companies. Over 180 of its portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange or Shenzhen Stock Exchange. There are also over 70 portfolio companies that have achieved unicorn status.

Meanwhile, Qiming US – which was set up in 2017- has raised over $550 million and boasts more than 30 portfolio companies, including Elevation Oncology.

Previous Post

Sleek secures Singapore payments license

Next Post

Tiger Global leads additional $10m funding in mental health startup Intellect

Related Posts

edit post
Auros
Featured

Trading platform Auros receives $17m in latest funding round

March 27, 2023
edit post
Gaspack
Featured

Gaspack scores additional funding from eMerge, Arise

March 27, 2023
edit post
Korean startup AITest.AI has established itself as a market leader in training to meet the growing demand for education in AI system testing. Recently, AITest.AI launched an innovative AI-testing training course on Udemy, a global e-learning platform, and has attained the topmost position in this field.
AI & Big Data

AITest.AI Emerges as Global Leader in Artificial Intelligence System Testing Training

March 24, 2023
edit post
PhonePe
Featured

Indian fintech PhonePe raises $200m more from Walmart

March 21, 2023
edit post
Antler
Featured

Antler to invest in over 30 startups in Indonesia this year

March 21, 2023
edit post
Heritas Capital
Venture Capital

Heritas Capital raises $20m for Asia Impact First Fund

March 20, 2023
Next Post
edit post
Intellect

Tiger Global leads additional $10m funding in mental health startup Intellect

Discussion about this post

No Result
View All Result

Follow Us

FREE NEWSLETTER




Copyright © 2023 AsiaTechDaily.com| About Us | Seed accelerator| Terms of Use| Privacy Policy| Cookie Policy Contact : [email protected] | DMCA.com Protection Status | trusted by Wimgo

No Result
View All Result
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • Gadgets & Electronics
    • Health & Bio
    • FinTech
    • IoT
    • Transportation & Logistics
    • Ecosystem
    • Marketplaces & E-commerce
    • Robotics
    • Investments
    • Featured
  • Deals
    • Private Equity
    • Venture Capital
    • IPO & Markets
  • Interviews
    • Startup Investing
    • Fundraising
    • Product Launching
  • MORE
    • Events
    • Startups Advice
  • Submit an Article
  • Forums
  • Jobs
  • REGISTER
  • Login

Copyright © 2023 AsiaTechDaily.com| About Us | Seed accelerator| Terms of Use| Privacy Policy| Cookie Policy Contact : [email protected] | DMCA.com Protection Status | trusted by Wimgo

We hope you enjoy our content, May you please give us Feedback regarding our website!

Single Post Feedback